Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2012 /
Developing technologies for personalised treatment

28th Sep - 2nd Oct 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.10.12
Views: 4646

Dr Atanasio Pandiella – Instituto de Biologia Molecular y Celular del Cancer, Salamanca, Spain

Dr Atanasio Pandiella talks to ecancer at the 2012 ESMO meeting in Vienna about the basis of personalised therapies for cancer and what the future holds for this type of treatment.


In addition, Dr Paniella talks about the impact that this will have on patients through more efficient treatment with less toxicity and minimising relapse.


Technologies that will help in these fields are proteomic and genomic technology that analyse the changes in alterations of the DNA in tumour cells, thus revealing potential targets.


The development of these therapies and technologies faces the challenge of costs and efficiency.


Filming supported by Amgen

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation